{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:29:45Z","timestamp":1790666985378,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Intramural Research Program"},{"name":"Center for Cancer Research"},{"DOI":"10.13039\/501100002387","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U554 ES16015"],"award-info":[{"award-number":["U554 ES16015"]}],"id":[{"id":"10.13039\/501100002387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002387","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01ES022186-01"],"award-info":[{"award-number":["1R01ES022186-01"]}],"id":[{"id":"10.13039\/501100002387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.bbadis.2015.02.012","type":"journal-article","created":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T19:31:10Z","timestamp":1425151870000},"page":"1242-1252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet"],"prefix":"10.1016","volume":"1852","author":[{"given":"Naoki","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher W.","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2015.02.012_bb0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver","volume":"1492","author":"Nishimura","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.molmet.2013.12.003","article-title":"Inventing new medicines: the FGF21 story","volume":"3","author":"Kharitonenkov","year":"2014","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molmet.2013.05.005","article-title":"Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones","volume":"2","author":"Adams","year":"2013","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1101\/gad.177857.111","article-title":"FGF21 regulates PGC-1\u03b1 and browning of white adipose tissues in adaptive thermogenesis","volume":"26","author":"Fisher","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0025","doi-asserted-by":"crossref","first-page":"12983","DOI":"10.1074\/jbc.M110.215889","article-title":"Thermogenic activation induces FGF21 expression and release in brown adipose tissue","volume":"286","author":"Hondares","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0030","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2119\/molmed.2011.00075","article-title":"Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21","volume":"17","author":"Chartoumpekis","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20140403","article-title":"FGF21 expression and release in muscle cells: involvement of MyoD and regulation by mitochondria-driven signaling","volume":"463","author":"Ribas","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molmet.2012.08.007","article-title":"The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue","volume":"2","author":"Adams","year":"2013","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0045","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0050","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0055","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2006-1168","article-title":"The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21","volume":"148","author":"Kharitonenkov","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0065","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1074\/jbc.273.10.5678","article-title":"Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)","volume":"273","author":"Aoyama","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0075","doi-asserted-by":"crossref","first-page":"7670","DOI":"10.1074\/jbc.M109.090175","article-title":"Control of steroid 21-oic acid synthesis by peroxisome proliferator-activated receptor alpha and role of the hypothalamic-pituitary-adrenal axis","volume":"285","author":"Wang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0080","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0085","doi-asserted-by":"crossref","first-page":"25123","DOI":"10.1074\/jbc.M112.375907","article-title":"Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21","volume":"287","author":"Cyphert","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0090","doi-asserted-by":"crossref","first-page":"e94996","DOI":"10.1371\/journal.pone.0094996","article-title":"Glucagon stimulates hepatic FGF21 secretion through a PKA- and EPAC-dependent posttranscriptional mechanism","volume":"9","author":"Cyphert","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0095","doi-asserted-by":"crossref","first-page":"254S","DOI":"10.3945\/ajcn.2009.28449B","article-title":"Fibroblast growth factor 21: from pharmacology to physiology","volume":"91","author":"Kliewer","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0100","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.27060","article-title":"Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1\u03b1-mediated antioxidant capacity in mice","volume":"60","author":"Ye","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0105","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1210\/en.2011-1496","article-title":"FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob\/ob mice from the toxicity of sepsis","volume":"153","author":"Feingold","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0110","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0115","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0120","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insight","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2362.2010.02338.x","article-title":"Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease","volume":"40","author":"Yilmaz","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0135","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2010.05.018","article-title":"Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride","volume":"53","author":"Li","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0140","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2012.10.029","article-title":"High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China","volume":"58","author":"Li","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0145","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.bbalip.2014.08.015","article-title":"Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet","volume":"1841","author":"Tanaka","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.25630","article-title":"Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis","volume":"56","author":"Tanaka","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0155","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","article-title":"Fibroblast growth factor-21 regulates PPAR\u03b3 activity and the antidiabetic actions of thiazolidinediones","volume":"148","author":"Dutchak","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0160","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cmet.2012.10.006","article-title":"Metabolomics identifies an inflammatory cascade involved in dioxin- and diet-induced steatohepatitis","volume":"16","author":"Matsubara","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0165","doi-asserted-by":"crossref","first-page":"G236","DOI":"10.1152\/ajpgi.00091.2010","article-title":"CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis","volume":"299","author":"Cazanave","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0170","doi-asserted-by":"crossref","first-page":"39336","DOI":"10.1074\/jbc.M111.280420","article-title":"Death receptor 5 signaling promotes hepatocyte lipoapoptosis","volume":"286","author":"Cazanave","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0175","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1074\/jbc.M114.605980","article-title":"Adipocyte-specific disruption of fat-specific protein 27 causes hepatosteatosis and insulin resistance in high-fat diet-fed mice","volume":"290","author":"Tanaka","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0180","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease","volume":"125","author":"Jiang","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0185","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1210\/en.2005-1494","article-title":"Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis","volume":"147","author":"Karaskov","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0190","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.febslet.2008.04.038","article-title":"FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity","volume":"582","author":"Arner","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0195","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/j.febslet.2009.09.012","article-title":"Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob\/ob mice","volume":"583","author":"Li","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0200","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI67353","article-title":"Interplay between FGF21 and insulin action in the liver regulates metabolism","volume":"124","author":"Emanuelli","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0210","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.gastro.2014.07.044","article-title":"Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets","volume":"147","author":"Fisher","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0215","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.24006","article-title":"Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning","volume":"53","author":"Ong","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0220","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biochi.2012.10.019","article-title":"Fibroblast growth factor 21 is induced by endoplasmic reticulum stress","volume":"95","author":"Schaap","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.bbadis.2015.02.012_bb0225","doi-asserted-by":"crossref","first-page":"29751","DOI":"10.1074\/jbc.M114.565960","article-title":"Fibroblast growth factor 21 is regulated by the IRE1\u03b1-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis","volume":"289","author":"Jiang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.02.012_bb0230","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2009.07.064","article-title":"Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice","volume":"137","author":"Johnson","year":"2009","journal-title":"Gastroenterology"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443915000630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443915000630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T15:26:52Z","timestamp":1537802812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443915000630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0925443915000630"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2015.02.012","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2015.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}